SEPTICYTE
LIVE

Serial Number

88777788

Owner

ImmuneXpress Pty Ltd

Attorney

LEIGH ANN LINDQUIST

Filing Date

Jan 29, 2020

Add to watchlist:

No watchlists yet
View on USPTO

SEPTICYTE Trademark

Serial Number: 88777788 • Registration: 6741924

SEPTICYTE is a trademark filed by ImmuneXpress Pty Ltd on January 29, 2020. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

ImmuneXpress Pty Ltd (6 trademarks)

425 Pontius Avenue. N., Suite 430
Seattle, WA 98109

Entity Type: 11

Trademark Details

Filing Date

January 29, 2020

Registration Date

May 31, 2022

Published for Opposition

March 15, 2022

Goods & Services

Clinical diagnostics for medical or veterinary use; biological chemical test kits comprised of medical diagnostic reagents and assays for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

Biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders, for diagnosis and treatment of sepsis

Medical services; medical pathology services; medical pathology services being the analysis of body fluid samples; medical services being molecular diagnostic services and taking of body fluid samples of others; providing information, advisory and consultancy services in relation to medical services, medical pathology services, the analysis of body fluid samples, medical services being molecular diagnostic services and taking of body fluid samples of others

Surgical and medical apparatus and instruments for use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; peripheral blood or immune cell diagnostic test apparatus for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders; diagnostic testing kits in this class consisting primarily of probes, buffers and reagents for use in microbial testing; point of care medical devices, namely, devices using nucleic acid amplification in the nature of real-time polymerase chain reaction or isothermal amplification, DNA sequencing or analyte quantification in the nature of mass spectrometry, protein array for analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 31, 2022 NRCC
REGISTERED-PRINCIPAL REGISTER
May 31, 2022 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 15, 2022 NPUB
PUBLISHED FOR OPPOSITION
Mar 15, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 23, 2022 NONP
CASE RETURNED TO EXAMINATION
Feb 8, 2022 OTHE
NOTICE OF ALLOWANCE CANCELLED
Feb 8, 2022 IUCN
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Feb 7, 2022 ATRQ
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Feb 7, 2022 PCBG
ASSIGNED TO PETITION STAFF
Feb 3, 2022 APET
TEAS PETITION TO AMEND BASIS RECEIVED
Jan 21, 2022 TPAD
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 10, 2021 EXRA
SOU EXTENSION 2 GRANTED
Dec 8, 2021 EX2G
SOU EXTENSION 2 FILED
Dec 8, 2021 EXT2
SOU TEAS EXTENSION RECEIVED
Dec 8, 2021 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 10, 2021 EXRA
SOU EXTENSION 1 GRANTED
Jun 8, 2021 EX1G
SOU EXTENSION 1 FILED
Jun 8, 2021 EXT1
SOU TEAS EXTENSION RECEIVED
Jun 8, 2021 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Dec 8, 2020 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 13, 2020 NPUB
PUBLISHED FOR OPPOSITION
Oct 13, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 23, 2020 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 7, 2020 CNSA
EXAMINER'S AMENDMENT ENTERED
Sep 7, 2020 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Sep 7, 2020 GNEN
EXAMINERS AMENDMENT E-MAILED
Sep 7, 2020 GNEA
EXAMINERS AMENDMENT -WRITTEN
Sep 7, 2020 CNEA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Apr 17, 2020 GNRN
NON-FINAL ACTION E-MAILED
Apr 17, 2020 GNRT
NON-FINAL ACTION WRITTEN
Apr 17, 2020 CNRT
ASSIGNED TO EXAMINER
Apr 17, 2020 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Feb 12, 2020 AMPX
ASSIGNED TO LIE
Feb 12, 2020 ALIE
ASSIGNED TO LIE
Feb 7, 2020 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 4, 2020 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Feb 3, 2020 PARI
NEW APPLICATION ENTERED
Feb 1, 2020 NWAP